Get in Touch
Award winning global experts in access for orphan drugs and
ATMPs
We partner with you to drive sustainable
access for patients with high unmet need
LEARN MORE
P4A are 100%
committed to the
rare disease community
learn more
We believe in realistic
and sustainable
patient access
» Driving patient access to appropriate treatments
» A fair return on investment for manufacturers
» At an affordable proposition for healthcare systems
Learn more
It is in our nature
to care about you
We employ highly experienced staff who genuinely
care about the circumstances people face, especially
those who are dealing with and treating rare diseases
Learn more
Our core values are pride, passion and partnership
» Pride in navigating complex access challenges
» Passionate to support the rare disease community
» Partnerships that are meaningful & collaborative
Learn more

We are the Orphan Drug Specialists

Committed to the cause

The P4A family are a unified andpassionate team who truly careabout access for orphan drugs and ensuring optimal client outcomes.
FIND OUT MORE ABOUT US

Client supporting services

We design bespoke solutions tosupport each commercialization journey; from initial clinical stage development to full maturity.
access success

Thought provoking insights

P4A’s knowledge of rare dieases is built on decades of experience. Discover how much we really know in our published output.
Wisdom & knowledge

With P4A you are
getting the best

Since 2015 we have been proud to partner and support clients who are at the forefront of creating groundbreaking new treatments and therapies.

P4A helped us develop a clear understanding of the environment and requirements for HTA authorities
- Health Economics & Outcomes Research Lead
P4A found us a solution that enables EU patients to access our gene therapy without breaking the bank
- Chief Commercial Officer
P4A showed our team that quality over quantity is a better approach to evidence gathering
- Global Program Leader
P4A helped us to devise a set of practical solutions that addressed payer uncertainties around our product
- Global Market Access Director
read our case studies

A world class team brimming with
expertise, passion and talent.

We carefully select and recruit the highest calibre of personnel. Every member of
our team is an expert in their field and passionate about access for Rare Diseases.

Sophie
Sophie
Aparna
Aparna
Akshay
Akshay
Stuart
Stuart
Owen
Owen
Georgie
Georgie
Joanna
Joanna
Chloe
Chloe
Andrea
Andrea
Nadia
Nadia
Fisentzos
Fisentzos
Olivia
Olivia
Erfan
Erfan
Meet the team

Our core services

As global experts in access for orphan drug, cell and gene therapy,
we truly understand the complexity and challenges of the market
access environment. P4A solutions are designed to be bespoke
to your situation, location and needs. One size does not fit all.

Evidence
Optimization

Value
Communication

Route to
Market

Access
Performance

Our solutions

Want to understand more about
what we do and how we do it?

Our 2-minute promotional video will give you a thorough overview
into P4A and our tailored, meticulous and innovative approach.

Awards

We are an award-winning global consultancy and recognised
for excellence in access for orphan drugs & ATMPs.

2022 | Best Rare Disease Access Consultancy
2022 | Leading Experts in Orphan Drug & Gene Therapy Access
2022 | Best Orphan Drug & Gene Therapy Experts
2022 | Analyst Team of The Year BOBI Awards
2021 | Best Global Cell & Gene Therapy Specialist
2020 | Best Specialist Biotech Market Access Consultancy Award
Read more

Find out what we’ve been up to

SEE ALL THE LATEST NEWS
SEE ALL THE LATEST NEWS
p4a-logo-small-retina-white

We are award winning global experts in access for orphan drugs and ATMPs.

Twitter Instagram Youtube Linkedin

About

Services

Insights

Case Studies

Contact